Cargando…
SUN-460 Anticipating Hypokalemia in Patients With ACTH-Dependent Cushing Syndrome Treated With Mifepristone: Utilization of Cortisol and ACTH Levels to Identify At-Risk Patients
Background: Hypokalemia (K+ level <3.5 mEq/L) is common in patients with hypercortisolism. Treatment with mifepristone, a glucocorticoid receptor antagonist, can exacerbate hypokalemia due to the mineralocorticoid effects produced by the rapid and significant increase in cortisol levels that resu...
Autores principales: | Moraitis, Andreas, Nguyen, Dat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553295/ http://dx.doi.org/10.1210/js.2019-SUN-460 |
Ejemplares similares
-
Hypercoagulability in ACTH-Dependent Cushing Syndrome
por: Singh Sumal, Amit Kartar, et al.
Publicado: (2021) -
MON-405 Cushing's Disease: An Oligosymptomatic Patient with ACTH-Secreting Pituitary Macroadenoma
por: Manrique Franco, Katty, et al.
Publicado: (2019) -
OR23-01 Intrapatient ACTH Variability in Cushing’s Disease: Prognostic Significance
por: Alvarez, Reinier, et al.
Publicado: (2020) -
SAT-248 Cushing’s Disease with Two ACTH-Producing Pituitary Tumors
por: Mathai, Christine, et al.
Publicado: (2020) -
THU009 Subclinical Cushing’s Syndrome In An ACTH-secreting Pituitary Macroadenoma
por: Akabogu, Nwamaka Gloria, et al.
Publicado: (2023)